ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical companyBaselAcadia Pharmaceuticals GmbH
Acadia Pharmaceuticals GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Acadia Pharmaceuticals GmbH operates in the pharmaceutical sector, developing and commercializing therapies for neurological disorders and rare diseases. Its clinical development includes programs in areas such as Prader-Willi syndrome, Alzheimer’s disease psychosis and essential tremor.

AI-generated
Offering

Products & services

LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Acadia Pharmaceuticals GmbH

Industry:Pharmaceutical company
✓ Offered7
Prescription medicines
FDA-approved treatments for Parkinson’s Disease Psychosis and Rett syndrome; includes NUPLAZID® (pimavanserin) and DAYBUE® (trofinetide).
Drug development for neurological diseases and rare diseases
Development of therapies in multiple clinical phases for Parkinson’s Disease Psychosis, Alzheimer’s Disease Psychosis, Rett syndrome, essential tremor and other indications.
Medical information for professionals
Scientific and medical information on Acadia products, research and development activities; including a contact option for healthcare professionals.
Scientific publications
Peer-reviewed publications and manuscripts on research, clinical findings and scientific development in neurology and rare diseases.
Clinical studies
Information on clinical studies for professionals, including ongoing studies and study participation in the area of neurological and rare diseases.
Independent Medical Education Grants
Acadia-funded grants for independent medical education for professionals.
Investigator-Initiated Studies
Information on studies supported by Acadia that are initiated by investigators in the field of neurological diseases and rare diseases.
Trust & reputation

ranQ Trust Score of Acadia Pharmaceuticals GmbH: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of November 2026

Without public customer reviews the score stays capped.

Acadia Pharmaceuticals GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Acadia Pharmaceuticals GmbH scores 88.1 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.92.512%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
Acadia Pharmaceuticals GmbH scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Acadia Pharmaceuticals GmbH scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Acadia Pharmaceuticals GmbH reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Acadia Pharmaceuticals GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Acadia Pharmaceuticals GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Acadia Pharmaceuticals GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Acadia Pharmaceuticals GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Barfüsserplatz 3
4051 Basel

At a glance

Legal form
Limited Liability Company
UID
CHE-435.458.844
Founded
2014 · 12 years
Last commercial register change
June 1, 2026
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
88.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.85.03%
  • Full methodology

    Similar companies

    RS
    Roivant Sciences GmbH
    Basel
    TG
    Taysha Gene Therapies Switzerland GmbH
    Basel
    SG
    Sandoz Group AG
    Basel
    SP
    Sumitomo Pharma Switzerland GmbH
    Basel
    AS
    Autolus Switzerland AG
    Basel
    IS
    Immunovant Sciences GmbH
    Basel
    UE
    Ultragenyx Europe GmbH
    Basel
    PF
    Pierre Fabre (Suisse) S.A.
    Basel